Approval · Notice of Compliance 4200 · 1996
PENTASA: Notice of Compliance 4200
Issued August 15, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4200
- Date
- August 15, 1996
- Company
- Hoechst Marion Roussel Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication
- Therapeutic class
- Gastrointestinal anti-inflammatory
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PENTASA | Not yet assigned | — |
Medicinal ingredients
- MESALAZINE 250 MG per TAB
- MESALAZINE 500 MG per TAB
- MESALAZINE 250 MG per CAP